{
    "code": "52026892",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026892",
    "time": "2024-04-11 19:55:13",
    "許可證字號": "衛部藥輸字第026892號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/08\/17",
    "發證\/登錄日期": "105\/08\/17",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202689200",
    "中文品名": "維帕特糖漿 10毫克\/毫升",
    "英文品名": "Vimpat Syrup 10mg\/ml",
    "適應症": "1.四歲以上有或無次發性全身發作的局部癲癇發作病人的單一藥物治療。\r\n2.輔助治療以下症狀：\r\n(1) 四歲以上複雜性局部癲癇發作(complex partial seizure)與單純或複雜性局部發作之合併有次發性全身發作(simple or complex partial seizure with secondary generalization)癲癇病人。\r\n(2) 四歲以上原發性全面強直陣攣發作(primary generalized tonic-clonic seizures; PGTCS)合併特發性全面癲癇發作(idiopathic generalized epilepsy)的病人。",
    "劑型": "184糖漿劑",
    "包裝": "200ml玻璃瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "108\/03\/25",
    "主成分略述": "Lacosamide",
    "限制項目": "02輸　入",
    "申請商名稱": "台灣優時比貿易有限公司",
    "申請商地址": "台北市松山區敦化北路88號12樓之2",
    "主製造廠": [
        {
            "製造廠名稱": "UNITHER MANUFACTURING LLC",
            "製造廠廠址": "331 CLAY ROAD, ROCHESTER, NY 14623, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "UCB PHARMA SA",
            "製造廠廠址": "ALLEE DE LA RECHERCHE 60, B-1070 BRUXELLES, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "AESICA PHARMACEUTICALS GmbH",
            "製造廠廠址": "MITTELSTRASSE 15, D-40789 MONHEIM AM RHEIN, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "外盒、包裝"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812002300",
            "成分名稱": "Lacosamide",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "200毫升裝之黃褐色玻璃瓶，聚丙烯材質的旋入性白色蓋子，附量杯與具轉接頭的給藥器。",
        "特殊劑型": "",
        "顏色": "無色到黃色或黃棕色",
        "特殊氣味": "草莓口味",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Vimpat syrup bottle_photo 2-111-05-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026892&Seq=002&Type=10"
        },
        {
            "title": "Vmpat syrup bottle photo 1-111-05-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026892&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI-VIMPAT syrup 10 MG_ML-110-12-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026892&Seq=005&Type=9"
        },
        {
            "title": "VIMPAT syrup 10 MG_ML 外盒標籤-110-12-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026892&Seq=005&Type=8"
        },
        {
            "title": "LBL_CIA76157B_MU2_VIMPAT_10MG_200ML_TWFDA2020-109-11-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026892&Seq=003&Type=8"
        }
    ]
}